Literature DB >> 9427778

Inverse correlation between bcl-2 expression and cell growth fraction in human endometrial adenocarcinoma tissue.

Y Kuwashima1, Y Kobayashi, M Kurosumi, J Tanuma, K Shiromizu, K Kishi.   

Abstract

Correlation between expression status of bcl-2 products and cell growth fraction (estimated by immunostaining for Ki-67 antigen) was analyzed in human endometrial adenocarcinoma tissue in situ. For this, serial sections, 2 micrometers thick, from formalin-fixed and paraffin-embedded tissue samples of 10 cases of the carcinoma were examined. Nine out of 10 carcinomas contained both bcl-2 positive and negative nests when examined immunohistochemically. In the remaining one case, no positive reaction for bcl-2 was observed. In general, bcl-2 positive nests tended to contain quiescent (Ki-67 negative) carcinoma cells, and bcl-2 negative nests, on the contrary, a large fraction of proliferating (Ki-67 positive) cells. However, this correlation was not strict, and in a few nests, the level of growth fraction was observed to be similar irrespective of bcl-2 positivity. These results show the complex function(s) of bcl-2 products, when considering their apoptosis-suppressing effects, cell cycle dependence and influence on cell proliferation status. Further, the results suggest an altered regulation of oncogene products in human solid tumor tissue in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427778

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study.

Authors:  A Zalatnai
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci.

Authors:  Robert H Pierce; Mary E Vail; Leah Ralph; Jean S Campbell; Nelson Fausto
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.

Authors:  T Itoi; K Yamana; V Bilim; K Takahashi; F Tomita
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.